MS News Roundup, Week of June 26th - July 2nd

Send us a text Welcome to this week's episode of the Multiple Sclerosis Weekly Update, where we cover the most recent and impactful news related to MS. This week, we delve into a groundbreaking study that reveals a genetic variant influencing the severity and progression of MS in certain patients. We also unpack a legal dispute between Biogen and Novartis over the biosimilar of Tysabri and explore what this means for branded biologic-drug makers. Additionally, we discuss the surprising impact...